Medicines for Malaria Venture (MMV) (External organisation)

Activity: Industry, Government and Philanthropy Engagement and PartnershipsPatentsPatent

Description

Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
US9238653B2 - United States
Period19 Jan 2016
Held atMedicines for Malaria Venture (MMV), Switzerland
Degree of RecognitionNational